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Abstract
As synthetic biology approaches are extended to diverse applications throughout medicine, 
biotechnology and basic biological research, there is an increasing need to engineer yeast, plant 
and mammalian cells. Eukaryotic genomes are regulated by the diverse biochemical and 
biophysical states of chromatin, which brings distinct challenges, as well as opportunities, over 
applications in bacteria. Recent synthetic approaches, including `epigenome editing', have allowed 
the direct and functional dissection of many aspects of physiological chromatin regulation. These 
studies lay the foundation for biomedical and biotechnological engineering applications that could 
take advantage of the unique combinatorial and spatiotemporal layers of chromatin regulation to 
create synthetic systems of unprecedented sophistication.
Synthetic biology provides a powerful framework to understand and harness biology. 
Biological components are assembled into well-controlled systems, enabling the systematic 
study of emergent properties and complex behaviours. Synthetic components and systems 
and the regulatory behaviours they encode can then be adapted by engineers for numerous 
applications — for example, controlling the dynamic expression of biosynthetic genes in 
industrial organisms, engineering sensors of environmental state and creating therapeutically 
relevant cell types. The core components that synthetic biologists have come to rely on, 
particularly transcriptional repressors and inducible promoters, were assembled in bacteria 
by early pioneers into genetic networks with switching1 and oscillating behaviours2, and 
these components have since been applied to engineer bacterial cells that can sense and 
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`remember' the presence of antibiotics in the mouse gut3. Importantly, by engineering 
connections between basic genetic units, these pioneering studies demonstrated the 
functional power of synthetic systems to directly test hypotheses about how complex 
regulatory behaviours arise and to create useful cellular devices.
As we confront new challenges in biology, medicine and biotechnology, there are great 
opportunities to apply synthetic biology approaches to higher-order organisms such as yeast, 
plants and mammals. Indeed, many of the synthetic components and gene networks 
developed in bacterial systems have been demonstrated to have utility in eukaryotic 
systems4. However, it is becoming increasingly clear that these types of regulatory systems 
alone are unlikely to drive and recapitulate the biological complexity of eukaryotic 
organisms. Eukaryotic genes are regulated in fundamentally different ways from bacterial 
genes5. A central distinguishing feature is the packaging of eukaryotic DNA into chromatin. 
Chromatin underlies the greater complexity of eukaryotic gene regulation and has been 
implicated in a broad range of industrially and biomedically relevant behaviours, including 
cellular responses to environmental stresses, cancer and stem cell differentiation6–12. More 
than a decade ago, synthetic biology provided a functional approach to test hypotheses 
surrounding genetic networks. It now has bright prospects for functionally testing and 
expanding our understanding of chromatin and harnessing its diverse roles in cellular 
regulation.
Chromatin is a constellation of DNA, proteins and RNA components that exists in diverse 
biochemical and conformational states (FIG. 1). Genomic DNA is wound around octamers 
of histone proteins (FIG. 1b), called nucleosomes, which are arrayed to form the `bead-on-a-
string' backbone of chromatin (FIG. 1c). Nucleosomes can be biochemically modified (FIG. 
1a) and spatially positioned on DNA, which itself can be methylated13, by the actions of 
hundreds of chromatin-modifying proteins. Nucleosomes also provide binding surfaces for 
these modifying proteins, as well as for transcription factors and nucleic acid polymerases14. 
Furthermore, nucleosomes alter the affinity of transcription factors for the underlying DNA 
through steric interactions15,16. In fact, there is intimate crosstalk between transcription 
factors and the chromatin state, and the genomic locations of one are a significant predictor 
of the other17. At larger scales (FIG. 1d), regions of chromatin on the same or different 
chromosomes can interact with each other and with subnuclear structures, thus sharing 
regulatory factors that can influence and coordinate gene expression18. Much of our 
understanding of chromatin comes from decades of work in molecular cell biology and 
biophysics, and it has recently accelerated through the generation of many genome-wide 
maps of chromatin components and structure19,20. This work has revealed a rich realm of 
spatiotemporal and combinatorial regulatory potential19,21. Synthetic approaches are 
providing functional complements to these high-resolution maps and revealing the roles of 
different chromatin features in generating complex regulatory behaviours. Moreover, by 
expanding our understanding of chromatin and ability to functionally manipulate it, 
synthetic systems could soon be engineered for a wide variety of human health and 
industrial applications.
This Review discusses recent progress at the intersection of chromatin biology and synthetic 
biology, highlighting synthetic approaches to study and control three major features of 
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chromatin structure: biochemical chromatin modifications, including their contribution to 
heritable and stable gene silencing through heterochromatin; nucleosome positioning; and 
spatial and topological conformations. We also consider the regulatory potential of non-
coding RNAs in BOX 1. We focus on how fundamental regulatory motifs are revealed by the 
synthetic manipulation of chromatin. Native chromatin biology has been reviewed in greater 
depth and detail elsewhere21,22. We conclude by discussing potential applications in 
medicine and biotechnology, as well as new technologies that may accelerate future work in 
synthetic chromatin biology.
Editing chromatin biochemistry
In 1964, Vincent Allfrey and colleagues radioactively labelled histones in vitro with 14C-
acetyl and 14C-methyl groups, which provided evidence for the post-translational 
modification of histones23. They went on to hypothesize that lysine acetylation reduces the 
electrostatic attraction of positively charged histones to negatively charged DNA: “as a 
charge neutralization mechanism, acetylation of the histones would be expected to modify 
DNA–histone interactions, and this may offer a molecular basis for the pronounced changes 
in histone acetylation and RNA synthesis during the course of gene activation” (REF. 24). 
This was an exciting hypothesis not only because of the mechanism it posited but also 
because it advocated a functional relationship between chromatin structure and gene 
expression. We now know that there are more than a dozen distinct types of histone 
modifications25, more than 60 modified amino acid residues of histones25, 2 of each histone 
type per nucleosome, and several different forms of DNA methylation. This combinatorial 
diversity creates a challenging problem for studying the individual and combinatorial roles 
of histone modifications; yet, it could underlie a powerful approach to synthetically set and 
tune expression states of synthetic genes without altering their DNA sequence. Thus, 
understanding the roles of these chromatin modifications has been a central goal in the past 
50 years and will continue to be so in the foreseeable future.
Is there a histone code?
An attractive hypothesis called the `histone code' posits that particular combinations of 
histone modifications are `read' by proteins to influence downstream functions26. There have 
been impressive efforts that mapped the genome-wide locations of chromatin modifications 
and correlated them to transcriptional states21. In addition, common experimental 
perturbations knock out or pharmacologically inhibit histone-modifying proteins to alter 
chromatin state. However, correlation and pleiotropy resulting from genome-wide 
perturbations often confound these approaches. Thus, for many specific histone 
modifications, it remains unclear whether they cause, result from or are unrelated to 
transcriptional activity27,28. Two complementary synthetic approaches that tackle these 
challenges are the generation of synthetic histone proteins to study the effects of 
modifications on specific amino acid residues, and the biochemical modification of 
nucleosomes at specific genomic locations in cells. In addressing the histone code 
hypothesis, these minimal synthetic approaches may also provide a `blueprint' for 
assembling chromatin components to derive useful regulatory logic and behaviours from the 
vast combinatorial space of histone modifications.
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Residue-specific modifications in synthetic histones
Synthetic histones have been extremely powerful tools to control the specific type and 
residue of histone modifications (FIG. 2A). The most comprehensive approaches were 
derived from chemical biology and unnatural amino acid techniques, and are able to mimic 
almost all modification types at any histone residue29. Chemical ligation of peptides with 
specific post-translational modifications to recombinant histones provides control over the 
modification type and the modified residue30 (FIG. 2Aa). These histones can be 
reconstituted into nucleosomes for in vitro studies31. A high-throughput method was 
recently developed to synthesize 54 chemically defined nucleosomes with distinct 
combinations of post-translational modifications32. These nucleosomes were incubated in 
vitro with histone-binding and histone-modifying proteins to assess the effects of histone 
modifications on the binding affinity of these proteins and on their catalytic activity towards 
other histone residues. Binding of the nucleosomes to barcoded DNA sequences followed by 
next-generation sequencing allowed all the different synthetic nucleosomes to be pooled for 
each assay. This increased throughput to thousands of experimental samples. Unnatural 
amino acids also provide a strategy to control the modification of specific histone 
residues33,34 (FIG. 2Ab). For example, Nguyen and colleagues replaced the histone H3 
lysine 9 (H3K9) residue with unnatural amino acids that could be chemically deprotected in 
vitro to reveal monomethyl35 and dimethyl36 lysines, and they used these recombinant 
histones to study the binding of heterochromatin protein 1 (HP1).
Although chemical ligation and artificial amino acid strategies generate highly homogeneous 
histones, they are difficult to implement in cells, but this remains a tantalizing possibility37. 
Instead, most methods in cells have relied on the generation of residue-specific histone 
mutants or the partial deletion of histone tails38,39 (FIG. 2Ac). In one of the most 
comprehensive studies so far, Dai et al.40 used gene synthesis to create a library of 486 
Saccharomyces cerevisiae mutants of histones H3 and H4. They substituted every amino 
acid in the complete histone proteins with alanine and every alanine with serine, and further 
substituted all lysine residues with arginine or glutamine to mimic the electrostatic charges 
of constitutively deacetylated or acetylated states, respectively. They also deleted segments 
of varying lengths from the amino-terminal tails of histones H3 and H4. By DNA barcoding 
each mutant, the yeast strains could be efficiently screened for a range of phenotypes, 
including fitness, sensitivity to heat shock, sensitivity to DNA damage, altered 
transcriptional elongation and altered transcriptional silencing. Fitness-related genetic 
interactions were also identified between specific histone mutants and Ubp8 and Set2, which 
regulate H2BK123 ubiquitylation and H3K36 methylation, respectively. In the future, this 
type of high-throughput approach could be extended to identify additional interdependencies 
between histone residues and chromatin-regulating proteins. It is also possible that particular 
histone modifications have different and potentially counterproductive effects on industrially 
relevant cellular properties, such as fitness, heat shock response and ethanol tolerance. 
Libraries of industrial yeast strains expressing mutant histones could be phenotypically 
screened to identify biosynthetic strains with desirable characteristics. Thus, residue-specific 
modifications in synthetic histones provide an important avenue both to study the 
combinatorial complexity of the histone code and to generate useful cellular properties and 
industrial cell strains.
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Site-specific chromatin modifications: evolving technologies
Synthetic histones provide unparalleled control over the types and residues of post-
translational modifications. However, they are limited to in vitro studies or to cellular studies 
of effects globally across the genome. As a complementary strategy, chromatin modifiers 
can be recruited to a particular genomic locus; such site-specific `epigenome editing' 
approaches help to avoid pleiotropic effects and provide evidence of whether chromatin 
modifications directly cause changes in gene expression (FIG. 2B). This approach also has 
broader functionality in terms of its ability to recruit activities besides histone modifications, 
including DNA methylation and nucleosome remodelling. Furthermore, site-specific control 
will be necessary to regulate specific genes or genomic regions for biomedical41 and 
biotechnological applications. The origin of synthetic site-specific regulators can be traced 
to early work in synthetic yeast transcription factors, in which the DNA-binding bacterial 
repressor LexA was fused to the transcriptional activator Gal4 (REF. 42). Since then, many 
chromatin modifiers have also been fused to DNA-binding domains (DBDs), as reviewed 
elsewhere43 (FIG. 2Ba).
More recently, DBDs that can be programmed to bind to almost any DNA sequence have 
been fused to chromatin modifiers (FIG. 2Ba). Programmable DBDs, such as zinc-finger 
(ZF) and transcription activator-like effector (TALE) proteins44, are important for several 
reasons. They enable modification of chromatin at essentially any endogenous locus without 
the need to insert synthetic DNA sequences, which is a key advancement over the use of 
artificial episomal or integrated DNA sequences (FIG. 2Bb). For example, endogenous 
genes were activated by ZF–Tet and TALE–Tet fusion proteins (which induce active 
demethylation of methylated cytosine)45,46 and were suppressed by ZF–DNA 
methyltransferases47–49 and ZF–H3K9 methyltransferases50,51. These studies provide strong 
evidence that DNA and H3K9 methylation are causative of gene repression, especially with 
the use of minimal H3K9 methyltransferase catalytic domains and catalytic mutants that 
failed to induce methylation and gene repression51. Endogenous targeting was also used to 
identify natural targets of enhancer regions52 (FIG. 2Bc). This was achieved by reducing the 
activities of enhancers with TALE–LSD1 (also known as KDM1A) fusions that 
demethylated H3K4, and identifying native targets of the enhancer by observing the 
resulting downregulation of proximal genes. Programmable DBDs also enable multiplex and 
combinatorial targeting, which has proved useful in several cases. For example, using ZFs, 
we recently co-recruited a library of 223 diverse chromatin-regulating proteins together with 
the commonly used transcriptional activator VP16, which provided a set of distinct, two-
input gene expression logic53. Other groups have used multiple ZFs to increase the site 
specificity of synthetic DNA methylation by fusing two co-dependent parts of a DNA 
methyltransferase to two distinct ZFs that bind to adjacent genomic sites54–56. Future work 
is likely to take advantage of highly multiplexible CRISPR–Cas9 systems57,58 to increase 
the throughput and technical ease of introducing multiple site-specific chromatin 
modifications. Indeed, Cas9 could enable large-scale `rewiring' or reprogramming of the 
chromatin network for research in stem cells, development, genomic stability and evolution. 
Furthermore, libraries of multiplexed site-specific chromatin modifiers could be used to tune 
the expression of biosynthetic or endogenous genes without the need to alter gene 
sequences, which enable rapid screening and engineering of production organisms.
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Site-specific chromatin modifications: heterochromatin and stable gene repression
Site-specific recruitment of chromatin modifiers also enables mechanistic studies of other 
complex behaviours such as gene expression `memory'. Indeed, chromatin has been 
extensively implicated in the establishment and maintenance of gene expression memory, so 
much so that the term epigenetic is often co-opted to refer to chromatin modifications in 
general. However, by a stricter definition, epigenetic refers only to gene expression states 
that are heritable through cell divisions. This is a crucial point, as it is clear that chromatin 
modifications alone do not transmit heritable `epigenetic' information. Instead, they must act 
in concert with RNA interference (RNAi) and protein factors through self-reinforcing 
feedback mechanisms to maintain memory59,60. As reviewed elsewhere59, much effort over 
the past several decades has focused on identifying these mechanisms and minimal 
components that give rise to heritable gene regulation, mainly in stable repressive regions 
called heterochromatin. Heterochromatin describes compact genomic regions that are often 
characterized by reduced histone acetylation, H3K9 trimethylation (H3K9me3) enrichment 
and occupancy of repressive proteins such as HP1.
Synthetic approaches have contributed to this area of research by demonstrating the 
causative functions of various chromatin regulators in the establishment of heterochromatic 
silencing. In particular, synthetically recruited heterochromatin proteins can demonstrate the 
requirement or sufficiency of DNA sequence elements, RNAi components, histone and DNA 
modifications, and regulatory proteins for memory, and such proteins can even induce 
heritable repression53,61–69. More recently, Ragunathan et al.70 showed that histone 
modifications and regulatory proteins are sufficient to establish stable heterochromatin in 
Schizosaccharomyces pombe, and that DNA sequence elements and RNAi are dispensable. 
They did so by transiently recruiting the S. pombe H3K9 methyltransferase Clr4 to a 
specific genomic location. This established a large domain of repressive H3K9me3 that was 
maintained over several mitotic and meiotic cell divisions in the absence of any DNA 
sequence elements, RNAi, DNA methylation or recruited Clr4. This supports a mechanism 
in which the histone modification, H3K9me3, and proteins, including Clr4, that both read 
and `write' H3K9me3 are able to propagate histone modifications over time and maintain 
heterochromatic memory. Interestingly, proteins that catalyse and remove H3K9me3 marks 
regulated the stability of this heterochromatic region, suggesting a potential way to tune this 
form of memory in engineering applications.
Recently, Hathaway et al.66 developed an inducible system that dynamically regulated (FIG. 
2Bd) the recruitment of HP1 and the strong synthetic transcriptional activator VP64 to a 
reporter locus in mouse embryonic stem cells. The associations of HP1 with the synthetic 
ZFHD1 DBD and of VP64 with the Gal4 DBD were controlled by the inducible 
dimerization domains of the FKBP–FRB system and the PYL–ABI system, respectively. 
This approach provided unprecedented temporal resolution of the kinetics of 
heterochromatin formation and reactivation and, through an accompanying quantitative 
model, insights into molecular mechanisms of heterochromatin establishment. Notably, the 
authors showed that the recruited HP1 protein could induce 10-kb regions of 
heterochromatic H3K9me3 after 5 days, and that this region was stable for at least 8 days 
after HP1 recruitment was washed out. Their model and data showed that the stability and 
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boundaries of the heterochromatic region were determined by a dynamic competition 
between placement of H3K9me3 marks and nucleosome turnover. An increase in DNA 
methylation was also measured; based on previous work that linked DNA methylation to 
stable heterochromatin69,71, this probably contributed to the observed gene repression 
memory. The continued development of this type of synthetic approach will be of particular 
interest to both chromatin biologists and synthetic biologists because memory and switch-
like elements are of tremendous importance in cell biology, as well as in biomedical and 
industrial applications.
Site-specific chromatin modifications: ongoing challenges
Future work in site-specific chromatin modification should address the substrate specificity 
of synthetic chromatin modifiers. For example, a histone acetyltransferase may acetylate 
many lysine residues on a histone and recruit other regulatory proteins through binding 
interactions. These potential nonspecific modifications and interactions need to be fully 
characterized. The use of catalytically dead mutant forms of chromatin modifiers could 
reveal their residue specificity, whereas the truncation of chromatin modifiers to minimal 
catalytic domains could reduce the recruitment of other regulatory proteins51.
Defining the binding specificities of the various customizable DNA-targeting platforms is 
also of considerable interest in the field. Although gene regulation activities tend to be the 
strongest at intended target sites, ZFs, TALEs and Cas9 can all exhibit substantial off-target 
binding as observed by various methods, and even minor off-target activities could be 
oncogenic or toxic72–79. Some strategies to improve the specificity of binding (or of effector 
activity) may include obligate pairs of DNA-binding or effector domains54,55,80,81; 
weakening binding affinities to individual nucleosides while increasing the overall length of 
the target DNA sequence82; and altering the length of DNA-binding arrays for ZFs and 
TALEs or the guide RNA for Cas9 targeting77,83,84.
Most work has focused on writing chromatin modifications, but complementary 
technologies for reading these modifications85 will be equally important if conditional 
feedback of basal or altered chromatin states is desired, for example, to inform downstream 
actions such as the writing of additional modifications. The ability to sense aberrant 
chromatin states in live cells could also be useful in diagnosing disease states such as cancer.
These chromatin-editing and chromatin-sensing technologies will require creative, new 
strategies to enhance control over substrate modifications and sensing in diverse chromatin 
contexts; address typically modest protein–nucleosome binding energies86; improve 
genomic site specificity; and stabilize chromatin-based memory. For example, to address 
weak binding energies, inspiration could be drawn from natural systems and proteins that 
bind to chromatin through multiple domains or increased avidity87.
In addition to these improvements, the prospects for site-specific chromatin modifiers are 
bright and are likely to involve the incorporation of diverse molecular engineering 
techniques that will provide enhanced spatiotemporal resolution. In one recent example, 
Konermann et al.88 fused chromatin modifiers and TALEs to the Cry2 and CIB1 protein 
domains, respectively. Illumination with blue light dimerized the Cry2 and CIB1 domains, 
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and dynamically localized chromatin modifiers to the DNA-bound TALE protein. These and 
other future systems may also adapt interesting biological systems that exhibit useful 
regulatory behaviours. For example, lowly expressed or non-expressed developmental genes 
have been observed to be `poised' for rapid activation by the presence of both active and 
repressive chromatin marks89. By engineering such bivalent states, this principle could be 
exploited for switch-like or adaptive responses in cellular engineering. Finally, although 
DBDs have mainly been used to effect changes in chromatin biochemistry, they can also 
recruit proteins that modulate many other useful aspects of chromatin biology (see below). 
In summary, site-specific chromatin modifications provide a powerful way to functionally 
study the roles of diverse chromatin-regulating activities and chromatin structures in gene 
expression.
Modulating nucleosome positioning
Beyond biochemical modifications, nucleosome positioning on DNA influences gene 
expression. Nucleosomes generally inhibit transcription by reducing accessibility of 
transcription factors and RNA polymerases to DNA90–92, thus creating a basally repressed 
state that contrasts with highly accessible bacterial DNA5. Both nucleosome-remodelling 
proteins and the underlying DNA sequence control nucleosome positioning93–95. Owing to 
the ease of manipulating genetic sequences, synthetic approaches have focused on the 
manipulation of DNA sequences to control nucleosome positioning and gene expression. For 
example, Raveh-Sadka et al.96 created a library of more than 70 promoter variants, each with 
different positioning and lengths of a poly(dA:dT) tract that is known to disfavour 
nucleosome binding. Using this system, the positioning of nucleosomes regulated the 
accessibility of transcription factors to DNA. This strategy provided a dynamic range of 
more than an order of magnitude in transcriptional activity. This highly tunable approach to 
design the strength of synthetic promoters could be useful in situations for which balancing 
the expression strength of different components is important for its behaviour, such as in 
genetic oscillators2.
In addition to controlling transcription levels, the positioning of nucleosomes can drive 
complex non-linear behaviours. For example, Lam et al.97 showed that, in yeast, 
nucleosomes can decouple the activation threshold of the PHO5 promoter from its dynamic 
range of expression. The activation threshold is controlled by the DNA-binding affinity of a 
protein that moves a nucleosome which originally blocks access of transcription factors to 
the promoter. When this nucleosome remodelling event is achieved, transcription factor 
binding sites uncovered in the promoter then determine the dynamic range. This type of 
regulation is reminiscent of a transistor in electrical engineering, in which the application of 
one signal allows the passage of a second signal, and could be used as a biological switch. 
Furthermore, the signal or protein expression level required to move the nucleosome and 
activate the PHO5 promoter could be engineered to be weaker than the protein expression 
level driven by the activated PHO5 promoter. This would essentially act as a signal amplifier 
that could be useful in circuit and cellular engineering. Future efforts could synthetically 
reposition nucleosomes by recruiting nucleosome remodellers (for example, SWI/SNF) to 
test other mechanisms that have been hypothesized to underlie complex behaviours, 
including the cooperative and switch-like activation or amplification of some genes98. These 
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types of experiments demonstrate how nucleosome formation and repositioning could 
contribute to sophisticated and potentially useful gene expression programmes.
Spatial features of chromatin
Synthetic biology has primarily abstracted genomic material as a repository of regulatory 
components and genes that produce proteins and RNA. Complex behaviours are derived 
from the interactions between these components through temporally dynamic genetic and 
biochemical networks. The chromatin scaffold provides a unique opportunity to engineer 
cellular systems that also function in spatial dimensions. The repetitive array of nucleosomes 
on DNA and the polymeric nature of chromatin provide the physical properties needed to 
regulate genes at both small and large spatial scales in the nucleus. For example, domains of 
DNA and histone modifications (such as H3K9me3) often cover multiple tandem genes. At 
larger spatial scales, genomic loci interact within and between chromosomes and also 
localize to subnuclear structures such as the nuclear lamina. Synthetic approaches that 
control these spatial features are deepening our understanding of chromatin biology and 
revealing emergent behaviours that could be useful in cellular engineering (FIG. 3).
Controlling boundaries of genomic activity
The juxta-position of sequence elements (DNA) and non-sequence elements (nucleosomes 
and DNA methylation) is an intriguing property of chromatin with profound and broad 
implications for gene regulation. For example, nucleosomes and methylated DNA bases 
provide a repetitive scaffold to which regulatory proteins can bind and propagate over large 
spatial regions that contain multiple genes. However, these regions and their boundaries 
must ultimately be controlled by DNA sequence elements. Synthetic tools have provided 
insights into this crosstalk between sequence and non-sequence elements. In particular, 
many studies have focused on how the boundaries of large regions of silent heterochromatin, 
which are often marked by DNA methylation and H3K9 methylation, are specified. It is 
thought that these regions are established by self-reinforcing mechanisms in which protein 
complexes bind to heterochromatic modifications and then catalyse the same modifications 
on adjacent nucleosomes or DNA.
Synthetic approaches have revealed various protein and sequence elements that can control 
the spreading of heterochromatic regions. Telomeres have been used as a natural source of 
heterochromatin, with auxotrophic markers inserted nearby as sensors of heterochromatic 
spreading. Using similar systems, various sequence elements have been inserted between the 
markers and telomeres, and identified as barriers to heterochromatic spreading. These 
include nucleosome-disrupting sequences99,100, transcriptionally active tRNA genes, 
binding sequences for synthetic transcriptional activators such as SAS2 fused to the DBD of 
GAL4 (REF. 101), and sequences tethered to the nuclear pore complex102 (FIG. 3A).
There are also boundaries of transcriptional activity within individual genes that can and 
need to be controlled. For example, most promoters have a limited extent of divergent 
transcription of non-coding sequences. Marquadt et al.103 integrated a synthetic bidirectional 
promoter, which drives divergent transcription of two distinct fluorescent proteins, into a 
yeast knockout library and found that divergent transcription increased in CAF-I-knockout 
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strains. As CAF-I regulates chromatin assembly, nucleosome positioning upstream of 
promoters probably limits divergent non-coding transcription. As more sophisticated 
synthetic gene expression systems are developed, both intragenic and intergenic boundary 
elements — such as CAF-I and nucleosome-disrupting sequences, respectively — will need 
to be used to avoid unintended spatial regulation.
Chromatin conformation and subnuclear interactions
Chromosomes exist in semi-restricted spatial domains within the nucleus called 
chromosome territories. In addition, the positioning of genomic loci within each 
chromosome is nonrandom, as is their positioning relative to subnuclear structures such as 
the nuclear lamina18,104. However, it is unclear whether these forms of spatial organization 
are just by-products of evolution or whether they have evolved for specific dynamic 
regulatory functions. Recent synthetic approaches have recapitulated some of these 
interactions, demonstrating that at least in some synthetic and physiological situations long-
range interactions and chromatin conformation exhibit function.
Synthetic approaches have demonstrated that transcriptional effectors recruited to sites more 
than 1 kb downstream of promoters can both activate105 and repress106 yeast genes through 
intrachromosomal looping. There is also evidence that looping can regulate genes at much 
greater distances. One prominent example is the β-globin gene that is regulated by its locus 
control region (LCR) positioned 40 kb away. Deng et al.107 demonstrated that this looping 
was causative of gene activation. They designed a ZF that binds to the β-globin promoter and 
fused it to Ldb1, a protein that is present at the LCR. The synthetic tethering of Ldb1 to the 
β-globin promoter was enough to recruit the LCR region through Ldb1–Ldb1 binding and 
resulted in activation of β-globin transcription (FIG. 3B). The authors also used the same 
strategy to reactivate the developmentally silenced fetal γ-globin promoter in primary adult 
murine erythroblasts108. This strategy could yield therapeutic benefits in patients with sickle 
cell anaemia or β-thalassemia by using gene therapy approaches to introduce looping factors 
into cells, thus inducing transcription of non-sickling γ-globin to replace defective adult β-
globin. Such potential therapeutics could be within reach in a decade or two, as there has 
been a recent resurgence in clinical trials of gene therapies109. This looping approach has 
several advantages, including the requirement of only a single ZF–Ldb1 factor for 
introduction into cells. Furthermore, the looping approach activated γ-globin expression by 
more than 1,000-fold, which is much stronger than the levels typically observed with 
synthetic activators. Thus, this strategy could lead to therapies that are more potent than the 
simple recruitment of transcriptional activators directly to the γ-globin promoter or the 
introduction of exogenous globin genes.
Chromatin–chromatin interactions also drive complex functions beyond gene activation. 
Noordermeer et al.110 tested whether the insertion of an artificial LCR onto a separate 
chromosome from the β-globin gene could activate β-globin transcription. They observed 
that interchromosomal interactions between the artificial LCR and the native β-globin gene 
were able to activate transcription, although this activation occurred only in rare `jackpot' 
cells. The authors hypothesized that rare long-range interactions might be a way for cells to 
stochastically generate phenotypic diversity and described this effect as `spatial effect 
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variegation'. In addition to activating individual genes such as β-globin, chromatin–
chromatin interactions can also temporally coordinate the expression of multiple genes, 
which could be useful in engineering the dynamic and ordered expression of different 
components in biosynthetic pathways. For example, active and inactive regions of the human 
genome tend to cluster together through predominantly intrachromosomal, as well as 
interchromosomal, contacts111. It is thought that regulatory factors, either activating112 or 
repressive113, are shared between spatially clustered genes, thus coordinating transcription 
regulation. Fanucchi et al.112 revealed an example of this coordination between the 
SAMD4A, TNFAIP2 and SLC6A5 genes, which are known to cluster in response to tumour 
necrosis factor-α (TNFα) exposure. They designed TALE nucleases to cleave each of the 
three loops that brought these genes together and measured changes in gene expression. 
They found that disrupting the chromatin contacts interfered with transcription of the other 
genes. Interestingly, this co-transcriptional effect was hierarchical. Some cleavage sites 
disrupted transcription of all three genes, whereas others affected only one or two genes.
In addition to intrachromatin interactions, chromatin also localizes with various subnuclear 
structures. Some subnuclear structures can be induced to form on chromatin by the tethering 
of specific proteins. For example, artificial kinetochores or centromeres can be created by 
the synthetic recruitment of specific proteins to DNA. When Ask1, a member of the Dam1–
DASH microtubule complex in S. cerevisiae, was fused to LacI and recruited to eight copies 
of genomically integrated lacO operator sites, it was able to trigger assembly of a synthetic 
kinetochore114. This kinetochore carried out many native functions, including bi-orienting 
sister kinetochores at metaphase, segregating sister chromatids and repairing errors in 
chromosome attachment. In another example, synthetic recruitment of the Clr4 H3K9 
methyltransferase to a euchromatic region in S. pombe promoted de novo centromere 
formation115. Synthetic control over centromere and kinetochore formation, coupled with 
knockouts of different centromere-related proteins, could reveal different roles of proteins in 
centromere establishment and function, including in regulating the fidelity and stability of 
the chromosome. Furthermore, the ability to engineer stable synthetic centromeres in 
synthetic chromosomes could be useful in expressing large cassettes that contain entire 
synthetic circuits, full biosynthetic pathways or large therapeutic genes that would be 
difficult to package in viruses for gene delivery (such as titin for various myopathies).
Synthetic tools can also be used to control the biophysical parameters of subnuclear 
structures, such as centromeres and kinetochores, to answer fundamental biological 
questions. In particular, it had been unclear how, during mitosis, the spindle checkpoint 
senses that paired chromosomes are attached to separate spindles. The general hypothesis 
was that when chromosomes were properly attached to separate spindles, the spindles would 
pull in opposite directions, which leads to a displacement either within kinetochore protein 
complexes or between the paired centromeres. To address this question, Nannas et al.116 
synthetically restricted the ability of centromeres to stretch by integrating lacO sites on 
either end of the centromere of chromosome III in haploid S. cerevisiae (FIG. 3Ca). By 
expressing tetrameric LacI complexes during mitosis, the outside ends of the paired 
centromeres were tethered together and restricted from moving apart. Tethering did not alter 
the spindle checkpoint or chromatid segregation, suggesting the checkpoint senses 
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intrachromosomal kinetochore strain rather than interchromosomal displacement between 
paired centromeres116.
Chromatin also localizes to other subnuclear structures that do not function as part of 
chromosomes. Some of these interactions are correlated with transcriptional activity. For 
example, the nuclear lamina is generally associated with repressed genes, whereas the 
nuclear pore is associated with active genes. Although the mechanisms underlying these 
correlations remain unclear, synthetic tethering of reporter genes to sub nuclear structures 
has been shown to alter gene expression61–64. In one example, Reddy et al.117 inserted an 
array of lacO operator sites downstream of a reporter gene. They also fused LacI to emerin, 
an inner nuclear membrane protein (FIG. 3Cb). Through interaction with LacI, the reporter 
was recruited to the nuclear membrane and silenced117. In a related experimental system, 
Kind et al.118 fused the nuclear lamina protein lamin B1 to the adenine methyltransferase 
dam. When they expressed the methyl-adenine-binding protein dpnI fused to the 
transcriptional activator VP16, the fusion protein was recruited and bound to methylated 
adenine bases located at the nuclear lamina. The dpnI–VP16 fusion protein then induced 
delamination of lamina-associated chromatin domains from the nuclear periphery. The 
authors hypothesized that activating transcription in lamina-associated chromatin domains 
induced their movement away from the nuclear periphery, which is consistent with the trend 
of a silent nuclear periphery117. Finally, in addition to controlling chromatin localization and 
conformations, synthetic DBDs such as LacI or Cas9 can also be used to recruit fluorescent 
proteins to observe the dynamic 3D structure of chromatin18,119,120. In summary, many rich 
behaviours arise from the conformations and subnuclear interactions of chromatin, and 
existing and future synthetic tools that control the spatial aspects of chromatin may reveal 
even more unique regulatory properties.
A bright future for synthetic chromatin biology
More than a decade ago, systems and synthetic biology enhanced our understanding of gene 
networks1,2,121,122. It is appealing to speculate how these fields may once again provide 
insights into the regulatory logic of chromatin5 and address the many open questions in 
chromatin and cell biology. The key advantages that synthetic approaches have provided are 
their ability to functionally perturb chromatin states with specificity in both histone residues 
and genomic locations. These attributes should continue to help researchers to determine the 
extent and validity of a histone code, as well as its functional role in the regulation of various 
molecular processes from gene expression activity and kinetics to DNA repair. Furthermore, 
although synthetic approaches often force the recruitment or manipulation of chromatin 
components in ways that are physiologically unnatural, their advantage is that they can 
identify the roles of context — for example, contexts in which regulation at one genomic site 
versus another or with specific combinations of components leads to distinct outcomes. 
Additionally, there has been recent and rapid development of technologies that expand our 
experimental capabilities, and it is exciting to speculate how the development and 
incorporation of these technologies could have substantial impacts on future research 
directions. For example, the synthetic construction of entire chromosomes123 could lend 
itself to studies that interrogate the relationships between regulatory DNA sequences, 
distances between genes and spatial chromosome conformation. Moreover, CRISPR–Cas9 
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technologies57,58,124 could enable tractable experiments that induce genome-wide rewiring 
of chromatin states and subsequent analyses of their effects on many biological processes, 
including cellular differentiation, proliferation and oncogenesis. Finally, optical tools125 
could probe chromatin dynamics at unprecedented spatiotemporal resolution, thus revealing 
the kinetics of gene activation and repression, memory formation and the relative order of 
action of different components in executing biological processes such as transcription.
In addition to expanding our fundamental understanding of biology, an ongoing achievement 
of synthetic biologists is the abstraction of biology into modular components with defined 
properties, which greatly streamlines design cycles for cellular engineering and applications. 
An intriguing question that remains is whether an analogous design framework is possible at 
the chromatin level and, if so, what form this framework might take. The most effective 
synthetic approaches will continue to benefit from the wealth of knowledge and conceptual 
thinking developed by chromatin biologists over the past 50 years. In fact, our fundamental 
understanding of chromatin has already had a substantial impact in identifying regulatory 
properties that could be harnessed in artificially engineered cellular systems for bioindustrial 
(FIG. 4A) and biomedical (FIG. 4B) applications. For example, spatially coordinated gene 
expression and multigene silencing53,70 could be used by metabolic and microbial engineers 
to efficiently regulate large biosynthetic cassettes in a manner that cannot be achieved by 
bacterial systems (FIG. 4Aa). The many barrier elements that have been identified99–102 
could also be used to control these regions of long-range regulation and prevent the 
spreading of regulation to endogenous genes. The direct role of chromatin in gene 
expression memory has been synthetically recapitulated53,66,70 and could be used to record 
and respond to environmental events to which cells are subjected, such as exposure to 
antibiotics, heat shock or toxins, or changes in cell density in a bioreactor (FIG. 4Ab). 
Finally, given the many ways to now target, modulate and modify chromatin, these 
approaches are likely to be used to correct disease-associated chromatin states in cancer, 
neurodegenerative diseases and many other conditions, or to artificially alter chromatin 
changes that are involved in developmental and differentiation pathways (FIG. 4B). Given 
that several epigenetic therapeutics, typically small-molecule inhibitors of chromatin-
modifying proteins, have already been used in the clinic86, more-specific strategies derived 
from synthetic biology approaches to intervene in epigenetic states could become promising 
next-generation therapeutic avenues in the near future. All of these types of applications are 
theoretically only as far from the clinic or the pilot plant as our ability to integrate them into 
existing synthetic biology frameworks. Initial applications of chromatin-based regulation in 
industry are likely to augment and enhance existing synthetic systems and organisms, and 
they could be closer to implementation than biomedical applications. Applications in 
biomedically relevant cell types will be slower to realize, as they are limited by our 
understanding of the role of chromatin in cellular regulation, as well as by the higher 
standard for off-target effects amid worries of the oncogenic potential of artificial factors. 
However, synthetic approaches will probably contribute substantially to our understanding 
of biomedical problems and present novels ways to address them.
Farther down the road, perhaps in the next two decades, we may truly begin to benefit from 
the regulatory sophistication of chromatin. We are only beginning to uncover the vast 
regulatory and `computational' potential of chromatin, including switch-like and 
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amplification behaviours at promoters through the positioning and modification of 
nucleosomes66,89,97,98. The combination of these behaviours with genetic networks could 
lay the foundation for the next generation of gene expression systems and circuits for 
programming cells. Synthetic circuits that incorporate chromatin-based components and 
regulatory functions could give rise to a new layer of sophistication and complexity in 
synthetic circuits and could be useful in programming `smart' and adaptive industrial 
organisms or long-term sentinel and therapeutic cells introduced into the human body.
In conclusion, synthetic biology has great potential to advance two broad goals: first, in 
providing tools and approaches to complement studies that address fundamental questions in 
biology; second, in developing an engineering framework to harness chromatin components 
for cellular engineering applications9,11,48,126,127. Our path to both goals will be accelerated 
by the continued collaboration between scientists and engineers. Given the broad importance 
of chromatin in most cellular processes and the many diseases with epigenetic components 
in their aetiology, collaborative efforts could have profound effects on our understanding of 
cell biology and our treatment of a vast number of diseases.
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Glossary
Nucleosomes Octamer protein complexes in which an octamer is comprised of 
two copies each of H3, H4, H2A and H2B histone proteins.
Non-coding RNAs Functional RNA molecules that are not translated into proteins.
Lysine acetylation A post-translational modification in which an acetyl group reacts 
with the primary amine on the side chain of a lysine residue.
Correlation A relationship between two or more variables. The correlation 
between the occupancy of a chromatin modification and 
transcriptional activity does not directly prove that the modification 
causes transcriptional activity, or vice versa.
Pleiotropy The phenomenon whereby one gene influences multiple other 
seemingly unrelated genes or traits.
Unnatural amino 
acid
An amino acid that is not naturally encoded or found in the genetic 
code of an organism.
Chemical ligation A chemical reaction that links a fully chemically derived peptide to 
the end of a recombinant protein.
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Zinc-finger (ZF). A small protein structural motif coordinated to one or more 
zinc ions that stabilize its fold.
Transcription 
activator-like 
effector
(TALE). A bacterial protein with a variable number of 34-amino-
acid repeats, of which 2 residues specify binding to a DNA base.
CRISPR (Clustered regularly interspaced short palindromic repeat). An 
important part of a prokaryotic adaptive immune system that uses 
short RNAs to guide the CRISPR-associated 9 (Cas9) nuclease to 
specific targets, which cleaves foreign DNA elements such as 
plasmids and phage genomes.
RNA interference (RNAi). A biological process that inhibits gene expression through 
RNA molecules interacting and interfering with specific mRNA 
molecules.
FKBP–FRB A protein pair consisting of FKBP and FRB, which dimerize by 
mutually binding to the small molecule rapamycin.
PYL–ABI A protein pair consisting of PYL and ABI, which dimerize by 
mutually binding to abscisic acid.
Avidity The accumulated strength of multiple affinities from multivalent 
non-covalent binding interactions.
Cry2 and CIB1 (Cryptochrome 2 and cryptochrome-interacting basic helix–loop–
helix 1). A pair of proteins that dimerize at the subsecond timescale 
upon blue-light exposure and that dissociate on the minute 
timescale.
Nuclear lamina A dense fibrillar network of intermediate filament proteins at the 
periphery of the nucleus.
Telomeres The regions at the ends of chromosomes comprised of repetitive 
nucleotide sequences that are typically repressed by 
heterochromatin.
Auxotrophic 
markers
Genes absent in an organism that normally produce organic 
compounds required for survival of the organism.
Yeast knockout 
library
A collection of yeast strains, each of which harbour a knockout 
allele for a single gene. Strains are either haploid and have a non-
essential gene knocked out, or diploid and have the knockout allele 
in a heterozygous state.
β-globin A subunit of the major haemoglobin complex found in adult 
mammals.
Locus control 
region
(LCR). A genomic region that enhances the expression of genes 
from a distance.
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Kinetochores The protein structures assembled on the centromere to which 
spindle fibres attach during cell division to pull sister chromatids 
apart.
Centromeres The genetic loci on chromosomes that link sister chromatids during 
mitosis and on which kinetochores assemble.
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Box 1 | Synthetic non-coding RNAs regulate chromatin structure
The terms chromatin and epigenetics evoke images of histones and DNA methylation. 
However, in order to direct chromatin components and modifications to specific genomic 
regions, it is clear that elements are required to provide sequence specificity. Some of this 
specificity arises from a bias in nucleosome occupancy based on the underlying DNA 
sequence and from transcription factors that bind to DNA motifs. More recently, non-
coding RNAs (ncRNAs) have been shown to be specificity elements as well. Synthetic 
approaches have provided evidence that these ncRNAs can act in diverse ways to regulate 
chromatin. In Schizosaccharomyces pombe, the RNA-induced transcriptional silencing 
(RITS) complex was hypothesized to target heterochromatin silencing components to 
DNA via small interfering RNA (siRNA) base-pairing. Buhler et al.128 showed that 
recruitment of RITS to a ura4 gene — through fusion of ura4 to BoxB mRNA hairpin 
sequences and fusion of the RITS component Tas3 to λN protein (which binds to BoxB) 
— induced silencing of ura4 (see the figure, part a). Additionally, siRNAs that targeted 
ura4 were generated and silenced an additional copy of ura4 in trans128.
In human females, the X chromosome is silenced in a phenomenon known as dosage 
compensation. The silent X chromosome expresses the long ncRNA X inactive-specific 
transcript (XIST) that coats the entire chromosome and induces heterochromatic 
silencing. Recently, using zinc-finger nucleases, the XIST cDNA was integrated into one 
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of the three copies of chromosome 21 in induced pluripotent stem cells (iPSCs) derived 
from an individual with Down syndrome (see the figure, part b). This silenced the third 
chromosome 21 and even rescued defects in proliferation and rosette formation in the 
iPSCs129. This type of synthetic approach could lead to `chromosome therapies' for other 
trisomy diseases. A recent study has demonstrated that ncRNAs can also function as 
barriers to heterochromatin spreading (see the figure, part c). Keller et al.130 discovered a 
long ncRNA termed BORDERLINE that prevented the spreading of pericentromeric 
heterochromatin on chromosome 1 in S. pombe. Interestingly, deleting BORDERLINE 
and synthetically replacing it with a ura3 cassette from Candida albicans maintained 
barrier activity, indicating that active expression of any RNA sequence is likely to be 
sufficient to block heterochromatin spreading.
Pol II, RNA polymerase II. Reprinted from Cell, 125, Buhler, M., Verdel, A. & Moazed, 
D., Tethering RITS to a nascent transcript initiates RNAi- and heterochromatin-
dependent gene silencing, 873–886, Copyright (2006), with permission from Elsevier.
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Figure 1. Regulatory features of chromatin at multiple length scales
a | The amino termini of histone proteins have numerous amino acid residues that can be 
biochemically modified, such as by the addition of methyl (Me), acetyl (Ac), ubiquitin (Ub) 
and phosphate (P) groups. These modifications influence the binding of DNA and regulatory 
proteins26. b | Genomic DNA, which itself can be methylated on cytosine residues, is wound 
around 4 pairs of histone proteins, which collectively comprise a nucleosome15. c | The 
positioning of nucleosomes on DNA influences the accessibility of transcription factors to 
regions such as the promoter. Regulatory proteins (orange, blue, red and purple) bind to 
nucleosomes, DNA and transcribed non-coding RNA (ncRNA). Histone marks (red circles) 
often appear in large spatial domains; their occupancy as a function of genomic position (red 
histogram) can be quantified using chromatin immunoprecipitation followed by DNA 
sequencing (ChIP–seq)19,21. d | Chromosomes exist in spatial territories in the nucleus. 
There are interactions within and between chromosomes, as well as between chromosomes 
and nuclear structures such as the nuclear pore, inner nuclear membrane and nuclear 
lamina18.
Keung et al. Page 25
Nat Rev Genet. Author manuscript; available in PMC 2016 April 26.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Synthetic control of biochemical chromatin modifications
Synthetic approaches provide two types of specificity: specificity in the histone residues that 
are modified (part A) and specificity in the genomic locations of histone modifications (part 
B). Aa | Synthetic histones can be created by ligating chemically defined peptides (red) to 
the amino termini of partial histone proteins that are produced recombinantly (grey)30–32. 
Ab | Artificial amino acids that are already biochemically modified can be incorporated into 
specific residues of histones that are recombinantly produced in bacteria33–37. This approach 
requires expression of an aminoacyl tRNA synthetase and an acetyl-lysine transporter to 
import exogenously supplied acetyl-lysine. Ac | Genetic mutations can change specific 
residues into ones that partially mimic the charge and shape of a modified histone 
residue38–40. Histones that are chemically synthesized or that contain artificial amino acids 
can be used in in vitro assays to measure changes in binding affinities to regulatory proteins 
or altered reactivity of specific histone residues due to the presence of modifications on 
other residues. Histones that were genetically mutated can be used in cellular assays to 
measure the effects of specific residues on global gene expression profiles. Ba | Chromatin-
modifying proteins with catalytic properties such as acetyltransferase or methyltransferase 
activities can be fused to DNA-binding proteins42–45,47,48,52–56. Bb–c | The fusion proteins 
bind to specific locations in the genome, altering gene expression of a downstream gene 
(part Bb) or genes that are targeted by a bound enhancer (part Bc). Bd | Chromatin modifiers 
can also be dynamically recruited to a genomic locus, allowing temporal measurements of 
changes in chromatin modifications53,66,70. TALE, transcription activator-like effector.
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Figure 3. Synthetic spatial control of chromatin
A | Several different types of barrier elements (red) can block the spreading of repressive 
heterochromatin. These include recruitment of transcriptional activators101, tethering to a 
nuclear pore complex102, insertion of actively transcribed tRNA genes or insertion of 
nucleosome-disfavouring DNA sequences99,100. B | The recruitment of a self-dimerizing 
protein can induce chromatin looping and localization of an enhancer or a locus control 
region (LCR) to a promoter107. This could localize factors that phosphorylate (P) and 
activate RNA polymerase II (Pol II). C | DNA-binding proteins can be used to answer 
biological questions, for example, whether the spindle checkpoint senses displacement 
between sister chromatids or within kinetochores116 (part Ca). Fusing DNA-binding 
domains to nuclear envelope proteins can localize (and often silence) specific genomic 
regions117 (part Cb). Part Ca adapted from REF. 116.
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Figure 4. Potential applications of synthetic chromatin biology
A | Eukaryotic organisms such as yeast are widely used in industry to produce diverse 
molecules that range from food flavourings to pharmaceuticals. Often, multiple biosynthetic 
genes need to be introduced into an organism's genome. Regulating many genes can be 
difficult, especially with many distinct promoters and other regulatory elements. Aa | In 
chromatin-based regulation, chromatin states such as heterochromatin can exert regulation 
over several kilobases of DNA through the simple recruitment of a repressor to a single 
location in the genome53,70. Barrier elements can be used to prevent spreading of repressive 
regulation into endogenous genes99–102. Ab | Repression of biosynthetic genes when cell 
densities are low promotes cell growth and fitness by avoiding taxing of cell resources. 
When cell densities in a bioreactor are optimal, the repressor can be degraded or diluted out, 
thus turning on expression of the biosynthetic genes. B | Chromatin has been widely 
implicated in many areas relevant to human health, including cell differentiation, cell 
proliferation, cell survival in different environmental conditions, epithelial-to-mesenchymal 
transition (EMT, which is relevant to cancer metastasis) and oncogenic potential6–12. 
Functional tools are lacking to directly perturb chromatin states at specific locations in the 
genome and to test hypotheses of their roles in these biomedical processes. Type II 
CRISPR–Cas9 DNA targeting technologies57,58 could be used to edit chromatin states at 
multiple genomic locations by fusing chromatin regulators to the Cas9 protein and 
expressing a library of guide RNAs that are complementary to genomic target sites.
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